New pancreatic cancer drug halts tumour growth in 90% of patients

A groundbreaking small-scale trial shows promise for a new pancreatic cancer drug that has halted tumor growth in an astonishing 90% of patients. This success raises significant hopes that the approach could be effective for other types of the disease, offering a potential breakthrough in treatment. While the trial is still small, the results are encouraging enough to warrant larger studies and further research into this innovative method, which could fundamentally change the landscape of pancreatic cancer treatment.

Original Source

Read the full article at Ft →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.